Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
出版年份 2019 全文链接
标题
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
作者
关键词
-
出版物
BMJ-British Medical Journal
Volume -, Issue -, Pages l4363
出版商
BMJ
发表日期
2019-07-25
DOI
10.1136/bmj.l4363
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial
- (2019) Francis Couturaud et al. HAEMATOLOGICA
- Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function
- (2017) Lucia Mazzolai et al. EUROPEAN HEART JOURNAL
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis
- (2017) Faizan Khan et al. BMJ Open
- Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
- (2017) Marc A Rodger et al. BMJ-British Medical Journal
- Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
- (2017) Marc A Rodger et al. BMJ-British Medical Journal
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)
- (2016) A.I. Franco Moreno et al. European Journal of Internal Medicine
- Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH
- (2016) C. Kearon et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study
- (2016) P. A. Kyrle et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort
- (2016) Marc A. Rodger et al. THROMBOSIS RESEARCH
- d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy
- (2015) Clive Kearon et al. ANNALS OF INTERNAL MEDICINE
- Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism
- (2015) Francis Couturaud et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Heterogeneity in Meta-analysis of FDG-PET Studies to Diagnose Lung Cancer
- (2015) Edward J. Mills et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
- (2014) EUROPEAN HEART JOURNAL
- Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis
- (2013) Paolo Prandoni ANNALS OF INTERNAL MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism
- (2013) Marc Carrier ANNALS OF INTERNAL MEDICINE
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
- (2013) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
- (2013) L. A. Castellucci et al. BMJ-British Medical Journal
- Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
- (2012) Timothy A. Brighton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin for Preventing the Recurrence of Venous Thromboembolism
- (2012) Cecilia Becattini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality and recurrence after treatment of VTE: Long term follow-up of patients with good life-expectancy
- (2011) Marianne S. Andresen et al. THROMBOSIS RESEARCH
- Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor
- (2010) Alfonso Iorio et al. ARCHIVES OF INTERNAL MEDICINE
- Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism
- (2010) M. J. KOVACS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
- (2008) M. A. Rodger et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started